Covidien plc 4
4 · Covidien plc · Filed Feb 12, 2014
Insider Transaction Report
Form 4
Covidien plcCOV
King Brian Douglas
Vice President
Transactions
- Exercise/Conversion
Ordinary Shares
2014-02-11$42.39/sh+9,661$409,530→ 46,772 total - Exercise/Conversion
Ordinary Shares
2014-02-11$39.18/sh+8,285$324,606→ 55,057 total - Sale
Ordinary Shares
2014-02-11$70.00/sh−17,946$1,256,220→ 37,111 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-02-11−8,285→ 8,286 totalExercise: $39.18Exp: 2020-11-30→ Ordinary Shares (8,285 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2014-02-11−9,661→ 19,322 totalExercise: $42.39Exp: 2021-11-30→ Ordinary Shares (9,661 underlying)
Footnotes (3)
- [F1]Also includes 83 shares acquired in connection with the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4.
- [F2]Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- [F3]Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.